This report provides a summary of the Midlands & East Hepatitis C ODN Educational Event held by HCV Action and NHS England in Nottingham on Friday 9th March 2018.
Resources
Drug services professional
Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country. Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.
Showing 181 to 190 of 204 resources
-
Summary report: Midlands & East Hepatitis C ODN Educational Event 2018
England, East Midlands, East of England, West Midlands Reports & Research PDF -
Summary report: National Hepatitis C ODN Stakeholder Event
This report provides a summary of the the breakout sessions held during the HCV Action & British Viral Hepatitis Group National Hepatitis C ODN Stakeholder Event, which took place at the University of Warwick on 4th July 2019. The breakout sessions were held in two parts, the first focusing on problem identification and the second on identifying solutions, and focused on the following topics: community outreach; reaching ethnic minority groups; treating in prisons; and engaging with local commissioners & other partners.England 30 Jul 2019 Training, Reports & Research, Strategy & Planning PDF -
Summary report: North East & Cumbria ODN Workshop, Newcastle
This report provides a summary of the North East & Cumbria ODN Workshop held by HCV Action, in partnership with the ODN, in Newcastle on Wednesday 3rd May 2017. The workshop brought together a range of stakeholders working across the hepatitis C pathway in the North East & Cumbria ODN region, with the aim of discussing some of the barriers faced by the ODN, as well as providing a forum in which to develop solutions to some of these challenges. The report includes summaries of the day's talks and group discussion, as well as suggested next steps to be taken following the event.North East, UK Reports & Research PDF -
Surveillance of hepatitis C testing, diagnosis and treatment in Scotland, 2019 update
This Health Protection Scotland report outlines that there were 1,423 new diagnoses of hepatitis C antibody-positivity in Scotland in 2018, the lowest number of new hepatitis C antibody diagnoses in Scotland since 1996. It is estimated that approximately 21,000 individuals were living with chronic hepatitis C infection in Scotland by the end of 2018 and approximately 10,500 of these have been diagnosed. A total of 2,609 individuals were initiated onto hepatitis C treatment during financial year 2018/19.Scotland 23 Jul 2019 Reports & Research PDF -
Tackling the problem of Hepatitis C, substance misuse and health inequalities: a Consensus for London
This document represents a call to action from experts in the fields of addiction and hepatitis in London. It provides a framework with which to address the epidemiological, clinical and financial challenges presented by current rates of hepatitis C among people who have injected drugs and sets out solutions in the form of a blueprint for local commissioners. It sets out key requirements and recommendations in terms of prevention, diagnosis, treatment and data collection for each type of service that impacts on the patient’s journey.Greater London 2011 Reports & Research, Strategy & Planning PDF -
Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis
This systematic literature review seeks to determine whether tattooing is a risk factor for the transmission of hepatitis C. A comprehensive search was performed to identify all case-control, cohort or cross sectional studies published prior to November 2008 that evaluated risks related to tattooing or risk factors of transmission of hepatitis C infection. A total of 124 studies were included in this systematic review, of which 83 were included in themeta-analysis.UK, Rest of World 2010 Reports & Research PDF -
The Hepatitis C Trust Outreach & Testing Van
This document summarises The Hepatitis C Trust’s Outreach and Testing Van service, which aims to increase diagnoses by reaching groups who may be at risk of hep C but who currently cannot, or do not, access testing through existing means. Given that most people in the UK today are undiagnosed, the testing van aims to overcome some of the key barriers to diagnosis.England 2011 Case study, Reports & Research PDF -
The lived experience of interferon-free treatments for hepatitis C: A thematic analysis
This research paper, published in the International Journal of Drug Policy, examines how interferon-free treatments for hepatitis C are being understood and experienced by patients.UK Reports & Research PDF -
The Sexual Health and Blood Borne Virus Framework 2011-15
Sexual health and blood borne viruses continue to be of high priority for the Scottish Government. The SexualScotland Aug 2011 Reports & Research PDF -
The Silent Pandemic: Tackling Hepatitis C with Policy Innovation
Hepatitis C may be the serious disease that most combines widespread prevalence with widespread ignorance. According to the World Health Organisation (WHO), this urgent public health problem kills 350,000 people per year, and 150 million have the chronic form of the hepatitis C virus (HCV). The incidence of new infections is simply not known at the global level. Yet, HCV is entirely preventable and largely curable.UK, Rest of World 2012 Reports & Research PDF